Business
Development
To build value in our vaccine adjuvant technology, we are interested in establishing partnerships with pharmaceutical companies or profit/non-profit institutions that are developing novel vaccines for human or veterinary use or seeking technologies to improve the immunogenicity of existing vaccines through alternative means of administration. CaPtivate is also able to license its technology and related know how for single or multiple applications on exclusive or non-exclusive basis with right to sublicense. Support in technology transfer and further development will be available.
Phone: 215-589-6359 |
Fax: 215-589-6324 |
Email: info@captivatepharma.com
Pennsylvania Biotechnology Center 3805 Old Easton Road, Doylestown, PA 18902-8400 US
